Refractory Chronic Immune-mediated Demyelinating Polyneuropathy - 21/07/20

Doi : 10.1016/j.ncl.2020.03.006

Aziz Shaibani, MD ^a,^b,^⁎ , Husam Al Sultani, MD ^a
^a Nerve and Muscle Center of Texas, 6624 Fannin Street Suite 1670, Houston, TX 77030, USA
^b Baylor College of Medicine, Houston, TX, USA

^∗Corresponding author. Nerve and Muscle Center of Texas, 6624 Fannin Street Suite 1670, Houston, TX 77030.Nerve and Muscle Center of Texas6624 Fannin Street Suite 1670HoustonTX77030

Resumen

Please verify term, “alternative”. Chronic immune-mediated demyelinating polyneuropathy (CIDP) is a treatable immune-related demyelinating polyneuropathy. Approximately 20% of cases do not respond to first-line therapies; most of these cases are due to alternative diagnoses, although some of them are due to severe CIDP. Unfortunately, a lack of universally accepted diagnostic criteria complicates the course of diagnosis and treatment. This article discusses videos of cases referred to a tertiary medical center for “refractory CIDP” and pitfalls in the diagnosis and management of this condition.

El texto completo de este artículo está disponible en PDF.

Keywords : Neuropathy, Demyelinating, CIDP, Refractory, Conduction block, POEMS, NF-155, MAG antibodies